
Patient Recruitment and Retention Services Market Report 2026
Global Outlook – By Patient Recruitment Steps (Pre-Screening, Screening), By Trial Phases (Phases I, Phases II, Phases III, Phases IV), By Therapeutic Areas (Cardiovascular Diseases, Oncological Disorders, Infectious Diseases, Central Nervous System Disorders, Respiratory Disorders, Hematological Disorders, Other Therapeutic Areas) - Market Size, Trends, And Global Forecast 2026-2035
Patient Recruitment and Retention Services Market Overview
• Patient Recruitment and Retention Services market size has reached to $4.25 billion in 2025 • Expected to grow to $5.69 billion in 2030 at a compound annual growth rate (CAGR) of 6.1% • Growth Driver: Clinical Trials Surge Unveiling The Boom In Patient Recruitment And Retention Services • Market Trend: Technological Advancements In The Patient Recruitment Services Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Patient Recruitment and Retention Services Market?
Patient recruitment and retention services refer to identifying and enrolling eligible participants with designed strategies and tactics to keep participants enrolled in clinical trials. It is used for clinical trials to complete the drug development cycle. The main patient recruitment steps of patient recruitment and retention services are pre-screening, and screening. Pre-screening refers to the process of checking a candidate's historical information to verify or screen a patient's background. The various trial phases include Phases I, phases II, phases III, and phases IV, which are used in various therapeutic areas such as cardiovascular diseases, oncological disorders, infectious diseases, central nervous system disorders, respiratory disorders, hematological disorders, and others.
What Is The Patient Recruitment and Retention Services Market Size and Share 2026?
The patient recruitment and retention services market size has grown strongly in recent years. It will grow from $4.25 billion in 2025 to $4.49 billion in 2026 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to reliance on manual patient recruitment methods, limited patient awareness about clinical trials, slower enrollment rates in early-phase trials, fragmented patient databases, dependency on local recruitment strategies.What Is The Patient Recruitment and Retention Services Market Growth Forecast?
The patient recruitment and retention services market size is expected to see strong growth in the next few years. It will grow to $5.69 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to increasing adoption of ai and digital recruitment platforms, rising focus on patient retention strategies, growing utilization of remote and decentralized clinical trials, integration of real-time monitoring and analytics, expansion of global patient recruitment networks. Major trends in the forecast period include increasing use of ai-driven patient identification and outreach, rising adoption of digital and media campaigns for recruitment, growing integration of genomic and biomarker data for patient matching, increasing utilization of virtual platforms for engagement and retention, rising deployment of real-time analytics for recruitment efficiency.Global Patient Recruitment and Retention Services Market Segmentation
1) By Patient Recruitment Steps: Pre-Screening, Screening 2) By Trial Phases: Phases I, Phases II, Phases III, Phases IV 3) By Therapeutic Areas: Cardiovascular Diseases, Oncological Disorders, Infectious Diseases, Central Nervous System Disorders, Respiratory Disorders, Hematological Disorders, Other Therapeutic Areas Subsegments: 1) By Pre-Screening: Patient Identification, Initial Outreach And Engagement, Eligibility Questionnaire, Patient Database Review, Digital And Media Campaigns For Recruitment 2) By Screening: In-Depth Eligibility Assessment, Medical History Review, Diagnostic Testing, Informed Consent Process, Clinical Trial Enrollment ConfirmationWhat Is The Driver Of The Patient Recruitment and Retention Services Market?
The rise in the number of clinical trials is driving the growth of the patient recruitment and retention services market. Clinical trials refer to a field of study that examines novel procedures and medications and assesses how they affect people's health results. Patient retention and recruitment services help to identify and register eligible participants in the study and support the development of clinical trials; as a result, the rise in the number of clinical trials increases the demand for the patient recruitment and retention services market. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry, a UK-based nonprofit organization, the number of industry-initiated clinical trials in the UK grew from 411 trials in 2022 to 426 trials in 2023, marking a 3.7% increase. Therefore, the rise in the number of clinical trials drives the patient recruitment and retention services industry.Key Players In The Global Patient Recruitment and Retention Services Market
Major companies operating in the patient recruitment and retention services market are IQVIA Holdings Inc, ICON PLC, Medpace Holdings Inc., Worldwide Clinical Trials Inc., Bioclinica Inc., Altasciences, BMC Group, Evolution Research Group (ERG), Science37, Veristat LLC, Elligo Health Research Inc., CROee Inc., Linical Co. Ltd, Clinrol, Antidote Technologies Inc., BBK Worldwide LLC, Integrated Clinical Trial Services (ICTS) Inc., Syneos Health Inc., Fidelis Research Ltd., S4 Research Pvt. Ltd, Clinical Accelerator Ltd., Polaris BioPharma Consulting Ltd, CSSi LifesciencesGlobal Patient Recruitment and Retention Services Market Trends and Insights
Major companies operating in the patient recruitment and retention services market are focusing on developing innovative solutions, such as advanced AI-driven recruitment platforms, to meet the rising demand for faster enrollment, improved retention, and more efficient clinical trial execution. AI-based recruitment systems analyze large volumes of patient data to identify eligible candidates more accurately, offering a more scalable and precise alternative to traditional manual screening methods that are time-consuming and resource-intensive. For instance, in March 2023, Aloha Health Network, a US-based artificial intelligence platform, launched an augmented AI/ML platform to accelerate patient recruitment in pharmaceutical clinical trials. The new service uses cutting-edge natural language processing (NLP) algorithms to find and pre-screen potential clinical trial volunteers using a variety of structured and unstructured data points, including electronic medical records and medical histories.What Are Latest Mergers And Acquisitions In The Patient Recruitment and Retention Services Market?
In January 2024, eMed, a U.S.-based telehealth and diagnostics provider offering on-demand virtual care and at-home testing, acquired Science 37 Holdings for an undisclosed amount. With this acquisition, eMed aims to broaden its reach into decentralized clinical trials by integrating Science 37’s patient-centric recruitment platform to accelerate enrollment and improve trial access. Science 37 is a US-based clinical research company operating a metasite model, recruiting fully consented patients remotely, obtaining their medical records, and facilitating e-consent to connect them with appropriate clinical studies.Regional Outlook
North America was the largest region in the patient recruitment and retention services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the patient recruitment and retention services market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Patient Recruitment and Retention Services Market?
The patient recruitment and retention services market include revenues earned by entities by providing services such as patient identification, data management, site support and training. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Patient Recruitment and Retention Services Market Report 2026?
The patient recruitment and retention services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the patient recruitment and retention services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Patient Recruitment and Retention Services Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $4.49 billion |
| Revenue Forecast In 2035 | $5.69 billion |
| Growth Rate | CAGR of 5.7% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Patient Recruitment Steps, Trial Phases, Therapeutic Areas |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | IQVIA Holdings Inc, ICON PLC, Medpace Holdings Inc., Worldwide Clinical Trials Inc., Bioclinica Inc., Altasciences, BMC Group, Evolution Research Group (ERG), Science37, Veristat LLC, Elligo Health Research Inc., CROee Inc., Linical Co. Ltd, Clinrol, Antidote Technologies Inc., BBK Worldwide LLC, Integrated Clinical Trial Services (ICTS) Inc., Syneos Health Inc., Fidelis Research Ltd., S4 Research Pvt. Ltd, Clinical Accelerator Ltd., Polaris BioPharma Consulting Ltd, CSSi Lifesciences |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
